Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Attracting a Positive Market
- HIV treatment medications must confront a difficult subject and still offer hope. The ads for HIV treatment medications can be found throughout the urban landscape, decorating a phone booth here, a billboard there, adding to a general acceptance of medical information in the public sphere. So how do companies position...
- White papers 2005-10-17
Additional Resources
- Foregoing Medical Treatment: A Dangerous Way to Cut Costs
- "Self-medicating" is what many people do to avoid a doctor's visit or ride out an illness. It may entail downing ibuprofen for days to suppress abdominal pain or abusing alcohol to minimize the mental anguish of undiagnosed bipolar disorder. A Consumer Reports study released today found another...
- Blog posts 2009-10-05
- Cobalis' EU Patent for PreHistin® Becomes Effective; Patent Protects Method of Treatment for Cobalis' PreHistin Anti-Allergy Medication
- IRVINE, Calif. -- Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company focused on the treatment of allergy and other atopic conditions, announced today that its Patent No. 1128835, titled "Cyanocobalamin Treatment in Allergic Disease," has been published by the European Patent Office in the European Patent Bulletin 06/25. With...
- Research articles 2006-06-21
- FDA Approves First IV Treatment for Postmenopausal Osteoporosis -- Boniva(R) Injection
- The U.S. Food and Drug Administration FDA has approved Boniva® ibandronate sodium Injection, the first intravenous IV medication for the treatment of postmenopausal osteoporosis, Roche and GlaxoSmithKline GSK announced today. Boniva Injection, the first quarterly medication for the treatment of postmenopausal osteoporosis, is a member of the bisphosphonate class, which...
- Research articles 2006-01-06
- Alkermes and Cephalon Receive FDA Approval of Vivitrol™ for the Treatment of Alcohol Dependence; First, Once-Monthly Injectable Medication Provides New Treatment Option; Companies to Host Conference Call at 4:30 p.m. EDT
- CAMBRIDGE, Mass. and FRAZER, Pa. -- Alkermes, Inc., (Nasdaq: ALKS) and Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration FDA has approved VIVITROLTM (naltrexone for extended-release injectable suspension) for the treatment of alcohol dependence. VIVITROL, the first and only once-monthly injectable medication for alcohol dependence,...
- Research articles 2006-04-13
- Hot Flashes in Men: Mayo Clinic Researchers Describe a Treatment; Mayo Clinic Proceedings Study Details Treatment With a New Antidepressant Medication.
- Byline: Mayo Clinic ROCHESTER, Minn., Oct. 12 AScribe Newswire -- A new antidepressant medication is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer, Mayo Clinic researchers report in the October issue of Mayo Clinic ...
- Research articles 2004-10-12
- Multiple Sclerosis Society of Canada: Acne Medication May Delay Progress of Multiple Sclerosis; Canadian researchers investigate common medication as alternative MS treatment.(Clinical report)
- CALGARY, ALBERTA, Oct 25, 2007 Marketwire via COMTEX -- A common acne medication that has been available for over 30 years has the potential to delay the progress of multiple sclerosis and if proven effective, will offer an inexpensive option for t CALGARY, ALBERTA, Oct 25,...
- Research articles 2007-10-25
- Allergy Treatment and Its Impact on Safety and Productivity: Implications of OTC Medication Availability on Employee Benefit Design
- This report is an overview of a medication access and utilization issue important to employee drug benefit design. Employers increasingly are analyzing links between health care, safety and productivity. As allergies are among the 10 most common health problems experienced by Americans, employers are looking at how these conditions can...
- White papers 2002-12-01
- Does Involuntary Outpatient Treatment Work?
- In most mental health systems there are people with severe mental illness who are prone to relapse, have repeated hospitalizations and criminal justice contacts, and disproportionately use the most costly services. Many also have alcohol or drug abuse problems. Such individuals often fail to take their prescribed medications, worsening their...
- White papers
- Spending for Specialized Mental Health Treatment in the VA: 1995-2001
- The department of veterans affairs VA provides health care to more than four million veterans annually. As the nation's largest provider of behavioral health services, the VA helps to define standards of care for U.S. mental health treatment. The shift from inpatient to outpatient care was accompanied by rapid increases...
- White papers 2004-03-11
- Prescription Drugs and the Changing Patterns of Treatment for Mental Disorders
- This white paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey MEPS to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result...
- White papers 2004-12-09
- Alkermes Announces Submission of New Drug Application for Vivitrex for Treatment of Alcohol Dependence
- CAMBRIDGE, Mass. -- Alkermes, Inc. (Nasdaq: ALKS) today announced that the Company has submitted a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") for marketing approval of VivitrexR (naltrexone long-acting injection), an investigational drug in development for the treatment of alcohol dependence. If approved, Vivitrex would...
- Research articles 2005-04-01
- Alkermes and Cephalon Issue Statement in Response to COMBINE Study Publication; Companies Partner to Make VIVITROL™, a New Treatment for Alcohol Dependence, Available in the U.S
- CAMBRIDGE, Mass. and FRAZER, Penn. -- The "Combining Medications and Behavioral Interventions for Alcoholism" COMBINE Study, published in the May 3, 2006 edition of the Journal of the American Medical Association(1), further supports the use of medication, medical management and psychosocial support to treat alcohol dependence. The study confirms the...
- Research articles 2006-05-02
- Egyptian president has new treatment, surgery in Germany delayed
- MUNICH, Germany AFP ? Egyptian President Hosni Mubarak received new medication at a clinic in Germany and his back operation will be delayed while it is tested, Egypt's Health Minister Mohammed Awad Tajeddin revealed. "The medical team treating President Mubarak has proposed postponing the surgery and to give the...
- Research articles 2004-06-21
- Kennedy to seek treatment for prescription addiction
- Rep. Patrick Kennedy said Friday he was entering treatment for addiction to prescription pain drugs after a middle-of-the-night car crash near the U.S. Capitol that he said he had no memory of. "That's not how I want to live my life," he declared. Kennedy, D-R.I., the son of...
- Research articles 2006-05-06
- ADHD treatment.(Attention Deficit Hyperactivity Disorder )(Brief Article)
- ADHD treatment. When treating children for attention-deficit/hyperactivity disorder, African-American parents had less positive views of stimulant treatment than white parents, according to new research from Johns Hopkins University and the Kennedy Kreiger Institute that will be presented at APHA. More African-Americans than...
- Research articles 2005-11-01
- US DEPT OF HHS: Scientists identify molecular target for tuberculosis drug treatment
- M2 PRESSWIRE-5 June 1998-US DEPT OF HHS: Scientists identify molecular target for tuberculosis drug treatment C1994-98 M2 COMMUNICATIONS LTD RDATE:040698 In a study with major implications for improving tuberculosis TB treatment, researchers have identified the exact part of the disease-causing microbe that is targeted...
- Research articles 1998-06-05
- Antipsychotic medication is effective in treating behavior problems in autistic children, Yale-based study shows.
- M2 PRESSWIRE-1 August 2002-YALE UNIVERSITY: Antipsychotic medication is effective in treating behavior problems in autistic children, Yale-based study shows C1994-2002 M2 COMMUNICATIONS LTD RDATE:08012002 New Haven, Conn. -- One of a newer class of antipsychotic medications was successful and...
- Research articles 2002-08-01
- Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
- STANFORD, Calif. -- A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine. But the results leave open the possibility that some medications, including the...
- Research articles 2007-03-15
- Healthy design treatment extends medical center's life. (Joslin Diabetes Center; building addition)
- Diabetic patients are urged to balance food, exercise and medication to keep their blood sugar as close to normal as possible. This treatment has been proven to prevent complications, helping patients to lead long and earthy lives. The project team that created the three-story...
- Research articles 1996-01-01
- << Previous
- page 1 of 1
- Next >>
